Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | JUN | P05412 | 1/20 | 1.00 |
| ▸ | MME | P08473 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 0.89 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.89 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.89 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.89 |
| ▸ | POLB | P06746 | 2/20 | 0.89 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.89 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.89 |
| ▸ | THRB | P10828 | 1/20 | 0.89 |
| ▸ | ATM | Q13315 | 1/20 | 0.89 |
| ▸ | GAA | P10253 | 3/20 | 0.77 |
| ▸ | LMNA | P02545 | 3/20 | 0.77 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.77 |
| ▸ | JAK2 | O60674 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclovalone SCHEMBL554417 | 1.00 | MEN1 (1.00) | MEN1KMT2AJUNMMENFKB1 | |
| Cyclovalone SCHEMBL29929726 | 1.00 | MEN1 (1.00) | MEN1KMT2AJUNMMENFKB1 | |
| Cyclovalone SCHEMBL554418 | 1.00 | MEN1 (1.00) | MEN1KMT2AJUNMMENFKB1 | |
| SCHEMBL24510580 | 0.94 | MAPT (1.00) | MEN1KMT2AJUNMMENFKB1 | |
| SCHEMBL6852865 | 0.94 | MAPT (1.00) | MEN1KMT2AJUNMMENFKB1 | |
| SCHEMBL6851610 | 0.94 | MAPT (1.00) | MEN1KMT2AJUNMMENFKB1 | |
| SCHEMBL29857079 | 0.94 | MAPT (1.00) | MEN1KMT2AJUNMMENFKB1 | |
| SCHEMBL16382595 | 0.90 | MEN1 (0.81) | MEN1KMT2AJUNMMENFKB1 | |
| SCHEMBL1524530 | 0.90 | MEN1 (0.82) | MEN1KMT2AJUNMMENFKB1 | |
| SCHEMBL28574116 | 0.90 | MEN1 (0.82) | MEN1KMT2AJUNMMENFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3177250-A1 | WETNESS INDICATOR WITH PERMANENT COLORANT | The Procter and Gamble Company (US) | 2017-06-14 | — | — | EP | claimed |
| CN-106573084-A | Wetness indicator with permanent colorant | 宝洁公司 | 2017-04-19 | — | — | CN | claimed |
| WO-2016022795-A1 | WETNESS INDICATOR WITH PERMANENT COLORANT | THE PROCTER & GAMBLE COMPANY (US) | 2016-02-11 | — | — | WO | claimed |
| US-20160038628-A1 | WETNESS INDICATOR WITH PERMANENT COLORANT | THE PROCTER & GAMBLE COMPANY | 2016-02-11 | — | — | US | claimed |
| WO-1993001824-A1 | COMBINATION THERAPY USING BIOFLAVONOID COMPOUNDS WITH ANTI-CANCER DRUGS | BAYLOR COLLEGE OF MEDICINE (US) | 1993-02-04 | — | — | WO | claimed |
| WO-2025100968-A1 | USE OF COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING DIABETIC KIDNEY DISEASE COMPRISING ZINC SALT AND CYCLO-HISPRO AS ACTIVE INGREDIENTS | 주식회사 노브메타파마 | 2025-05-15 | — | — | WO | disclosed |
| EP-3348267-B1 | TRPV1 INHIBITOR FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY | UNIV HAWAII (US) | 2024-01-10 | — | — | EP | disclosed |
| EP-3348267-A1 | METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY | University Of Hawaii (US) | 2018-07-18 | — | — | EP | disclosed |
| EP-2635281-B1 | METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY | UNIV HAWAII (US) | 2018-03-14 | — | — | EP | disclosed |
| EP-3177250-A1 | WETNESS INDICATOR WITH PERMANENT COLORANT | The Procter and Gamble Company (US) | 2017-06-14 | — | — | EP | disclosed |
| CN-106573084-A | Wetness indicator with permanent colorant | 宝洁公司 | 2017-04-19 | — | — | CN | disclosed |
| US-20160038628-A1 | WETNESS INDICATOR WITH PERMANENT COLORANT | THE PROCTER & GAMBLE COMPANY | 2016-02-11 | — | — | US | disclosed |
| US-20100029763-A1 | METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES | UNIVERSIDADE BANDEIRANTE DE SAO PAULO-ACADEMIA, PAULISTA ANCHIETA S/C LTDA (BR) | 2010-02-04 | — | — | US | disclosed |
| EP-2054365-A2 | METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES | Uniban - Universidade Bandeirante De São Paulo (BR) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008003155-A2 | METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES | UNIBAN - UNIVERSIDADE BANDEIRANTE DE SÃO PAULO - ACADEMIA PAULISTA ANCHIETA S/C LTDA (BR) | 2008-01-10 | — | — | WO | disclosed |
| US-20070060644-A1 | Therapeutic curcumin derivatives | STC.UNM | 2007-03-15 | — | — | US | disclosed |
| US-20060276536-A1 | Cancer treatment using curcumin derivatives | STC.UNM | 2006-12-07 | — | — | US | disclosed |
| WO-1993001824-A1 | COMBINATION THERAPY USING BIOFLAVONOID COMPOUNDS WITH ANTI-CANCER DRUGS | BAYLOR COLLEGE OF MEDICINE (US) | 1993-02-04 | — | — | WO | disclosed |
| US-RE30267-E | SEMIPERMEABLE MEMBRANE, THIN FILM | EASTMAN KODAK COMPANY (US) | 1980-05-06 | — | — | US | disclosed |
| US-4066403-A | DECOMPOSITION, PERMEABLE BARRIERS | EASTMAN KODAK COMPANY (US) | 1978-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060644-A1 | Therapeutic curcumin derivatives | FABP2, GLS2, FABP1 | MEN1 3638/4885KMT2A 4131/4885JUN 2204/4885 |
| US-20100029763-A1 | METHODS TO PREPARE PENTA-1,4-DIEN-3-ONES AND SUBSTITUTED CYCLOHEXANONES AND DERIVATIVES WITH ANTITUMORAL AND ANTIPARASITIC PROPERTIES, THE COMPOUNDS AND THEIR USES | CASP3, CYP8B1, DERA | MEN1 1364/4885KMT2A 3228/4885JUN 4511/4885 |
| US-20060276536-A1 | Cancer treatment using curcumin derivatives | BRCA1, VHL, TP53 | MEN1 1379/4885KMT2A 846/4885JUN 786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.